Ironwood Pharmaceuticals (IRWD) Total Liabilities (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Total Liabilities across 17 years of filings, most recently posting $447.0 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 31.35% year-over-year to $447.0 million; the TTM figure through Jun 2026 stood at $447.0 million (down 31.35% YoY), while the FY2025 annual figure was $658.7 million, up 1.0% from the prior year.
• Total Liabilities came in at $447.0 million for Q2 2026 at Ironwood Pharmaceuticals, down from $651.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $950.0 million in Q2 2023 to a low of $442.8 million in Q2 2022.
• Average Total Liabilities over 5 years is $641.2 million, with a median of $655.5 million recorded in 2024.
• Year-over-year, Total Liabilities surged 114.54% in 2023 and sank 31.35% in 2026.
• Over 5 years, Total Liabilities stood at $448.1 million in 2022, then surged by 82.39% to $817.4 million in 2023, then decreased by 20.2% to $652.2 million in 2024, then increased by 1.0% to $658.7 million in 2025, then sank by 32.15% to $447.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $447.0 million in Q2 2026, $651.7 million in Q1 2026, and $658.7 million in Q4 2025.